AVITA Medical, Inc.
$4.12
The Read: RCEL's stock rallied sharply on positive management commentary easing cash burn concerns, analyst optimism alleviating dilution fears, and regulatory approvals plus leadership stability boosting confidence, but showed muted reaction when Q1 earnings met estimates without upside surprises.
Price
Overlays
Panel
RCEL
Hover to view data
No Data